SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
59 hedge funds and large institutions have $81.2M invested in Sierra Oncology, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
Holders
59
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$390K | |
| 2 | +$239K | |
| 3 | +$200K | |
| 4 |
Renaissance Technologies
New York
|
+$148K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$136K |
Top Sellers
| 1 | -$843K | |
| 2 | -$458K | |
| 3 | -$341K | |
| 4 |
O
OrbiMed
New York
|
-$171K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$165K |